Literature DB >> 18171255

Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis.

Vivian H Chu1, Christopher W Woods, Jose M Miro, Bruno Hoen, Christopher H Cabell, Paul A Pappas, Jerome Federspiel, Eugene Athan, Martin E Stryjewski, Francisco Nacinovich, Francesc Marco, Donald P Levine, Tom S Elliott, Claudio Q Fortes, Pilar Tornos, David L Gordon, Riccardo Utili, Francois Delahaye, G Ralph Corey, Vance G Fowler.   

Abstract

BACKGROUND: Coagulase-negative staphylococci (CoNS) are an infrequent cause of native valve endocarditis (NVE), and our understanding of NVE caused by CoNS is incomplete.
METHOD: The International Collaboration on Endocarditis-Prospective Cohort Study includes patients with endocarditis from 61 centers in 28 countries. Patients with definite cases of NVE caused by CoNS who were enrolled during the period June 2000-August 2006 were compared with patients with definite cases of NVE caused by Staphylococcus aureus and patients with NVE caused by viridans group streptococci. Multivariable logistic regression was used to determine factors associated with death in patients with NVE caused by CoNS.
RESULTS: Of 1635 patients with definite NVE and no history of injection drug use, 128 (7.8%) had NVE due to CoNS. Health care-associated infection occurred in 63 patients (49%) with NVE caused by CoNS. Comorbidities, long-term intravascular catheter use, and history of recent invasive procedures were similar among patients with NVE caused by CoNS and among patients with NVE caused by S. aureus. Surgical treatment for endocarditis occurred more frequently in patients with NVE due to CoNS (76 patients [60%]) than in patients with NVE due to S. aureus (150 [33%]; P=.01) or in patients with NVE due to viridans group streptococci (149 [44%]; P=.01). Despite the high rate of surgical procedures among patients with NVE due to CoNS, the mortality rates among patients with NVE due to CoNS and among patients with NVE due to S. aureus were similar (32 patients [25%] and 124 patients [27%], respectively; P=.44); the mortality rate among patients with NVE due to CoNS was higher than that among patients with NVE due to viridans group streptococci (24 [7.0%]; P=.01). Persistent bacteremia (odds ratio, 2.65; 95% confidence interval, 1.08-6.51), congestive heart failure (odds ratio, 3.35; 95% confidence interval, 1.57-7.12), and chronic illness (odds ratio, 2.86; 95% confidence interval, 1.34-6.06) were independently associated with death in patients with NVE due to CoNS (c index, 0.73).
CONCLUSIONS: CoNS have emerged as an important cause of NVE in both community and health care settings. Despite high rates of surgical therapy, NVE caused by CoNS is associated with poor outcomes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18171255     DOI: 10.1086/524666

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  41 in total

1.  [Septic arthritis as an initial manifestation of a bacterial endocarditis].

Authors:  M Gothner; T Ramczykowski; A Ewers; T Kälicke; S Shah; T A Schildhauer; J Swol
Journal:  Unfallchirurg       Date:  2013-05       Impact factor: 1.000

2.  Evolution of nasal carriage of methicillin-resistant coagulase-negative staphylococci in a remote population.

Authors:  David Lebeaux; François Barbier; Cécile Angebault; Lahcene Benmahdi; Etienne Ruppé; Benjamin Felix; Kevin Gaillard; Félix Djossou; Loïc Epelboin; Claire Dupont; Magaly Renard; Gilles Peroz; François Vandenesch; Michel Wolff; Antoine Andremont; Raymond Ruimy
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

3.  Value of PCR in surgically treated patients with staphylococcal infective endocarditis: a 4-year retrospective study.

Authors:  B Zaloudíková; E Němcová; J Pol; Z Sorm; S Wurmová; K Novotná; M Vaněrková; V Holá; F Růžička; L Dušek; P Němec; T Freiberger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-02       Impact factor: 3.267

4.  Implementation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry in Routine Clinical Laboratories Improves Identification of Coagulase-Negative Staphylococci and Reveals the Pathogenic Role of Staphylococcus lugdunensis.

Authors:  Xavier Argemi; Philippe Riegel; Thierry Lavigne; Nicolas Lefebvre; Nicolas Grandpré; Yves Hansmann; Benoit Jaulhac; Gilles Prévost; Frédéric Schramm
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

5.  Virulence factors associated with Coagulase Negative Staphylococci isolated from human infections.

Authors:  K R Soumya; Suja Philip; Sheela Sugathan; Jyothis Mathew; E K Radhakrishnan
Journal:  3 Biotech       Date:  2017-06-08       Impact factor: 2.406

6.  Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure.

Authors:  Todd Kiefer; Lawrence Park; Christophe Tribouilloy; Claudia Cortes; Roberta Casillo; Vivian Chu; Francois Delahaye; Emanuele Durante-Mangoni; Jameela Edathodu; Carlos Falces; Mateja Logar; José M Miró; Christophe Naber; Marie Françoise Tripodi; David R Murdoch; Philippe Moreillon; Riccardo Utili; Andrew Wang
Journal:  JAMA       Date:  2011-11-23       Impact factor: 56.272

7.  Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis.

Authors:  C García-de-la-Mària; F Marco; Y Armero; D Soy; A Moreno; A del Río; M Almela; C Cervera; S Ninot; C Falces; C A Mestres; J M Gatell; M T Jiménez de Anta; J M Miró
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

Review 8.  Infective Endocarditis in the Elderly: Diagnostic and Treatment Options.

Authors:  M P Ursi; E Durante Mangoni; R Rajani; J Hancock; J B Chambers; B Prendergast
Journal:  Drugs Aging       Date:  2019-02       Impact factor: 3.923

9.  Daptomycin for methicillin-resistant Staphylococcus epidermidis native-valve endocarditis: a case report.

Authors:  Marylene Duah
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-02-18       Impact factor: 3.944

10.  Analysis of the genotype and virulence of Staphylococcus epidermidis isolates from patients with infective endocarditis.

Authors:  Alastair B Monk; Sam Boundy; Vivian H Chu; Jill C Bettinger; Jaime R Robles; Vance G Fowler; Gordon L Archer
Journal:  Infect Immun       Date:  2008-09-15       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.